Author: Divya Sharma (Divya Sharma)

JBPL Dubai
Post

Jindal Biotech deepens investment in the Middle East to capitalize on increased demand for quality medical consumables

DUBAI, February 21, 2021 – Jindal Biotech Private Limited (JBPL), a leading manufacturer of medical and surgical consumables, today announced the expansion of its operations with the opening of its office in Dubai UAE. The Dubai office will serve as the central hub for JBPL’s business development and marketing efforts in the Middle East and...

Jindal Biotech Products
Post

Jindal Biotech Private Limited inks INR 20 Crores deal with Cure21 Biosciences

MoU signed between both the companies is for over INR 20 Crores, spread over the next few years. Indore, Madhya Pradesh – Jindal Biotech Pvt Ltd (JBPL) and Cure21 Biosciences Pvt. Ltd. are pleased to announce that they have entered into a strategic alliance, combining JBPL’s products across Medical Cotton, Dressings and Bandages with Cure21 Bioscience’s footprint...

COVID-19 vaccination and demand of syringes in India
Post

COVID-19 vaccination and demand of syringes in India

The central government has ordered 83 crore syringes for COVID-19 vaccination drive in India. A set of guidelines for safer disposal of used injections has also been prepared, according to reports. Moreover, the centre has also invited bids for 35 crore more syringes, according to the statement by union ministry of health and family affairs. The...

Post

Medical Device Registration and CDSCO Approval

The Indian medical regulatory system has become more complicated in recent years. In the past, medical devices did not need to be approved at all, but that is not the case today. In India, there are about 30 device “families” that outline which specific medical devices need to be registered. With the rising opportunities in...